|
|
||||||||
Basic Science Investigations |
1 Centre dExploration et de Recherche Médicales par Émission de Positons, Biomedical Cyclotron, Lyon, France
2 Institut National de la Santé et de la Recherche Médicale, Unité 512, Neurochimie et Neuropharmacologie, Lyon 1 University, Lyon, France
3 Cyclotron Research Center, Liège University, Liège, Belgium
4,2'-(Methoxyphenyl)-1-[2'-(N-2''-pyridinyl)-p-fluorobenzamido]ethylpiperazine (18F-MPPF) is a radiotracer used in clinical PET studies for the visualization of serotonin-1A (5-HT1A) receptors. In a previous study, we demonstrated that a rapid enhancement of extracellular serotonin concentrations influences 18F-MPPF-specific binding. Because endogenous serotonin is significantly decreased in some pathologies, the aim of this study was to determine whether 18F-MPPF is sensitive to depletion of this neurotransmitter. Methods: Using the ß-microprobe, an original ß+-sensitive intracerebral probe, and microdialysis, the effect of decreased serotonin on the specific binding of 18F-MPPF to 5-HT1A receptors was investigated in the hippocampus of the anesthetized rat. Extracellular serotonin was pharmacologically decreased in the hippocampus after a single injection of p-ethynylphenylalanine ([p-EPA] 5 mg/kg), a new tryptophan hydroxylase inhibitor. Results: Our results showed that the 18F-MPPF-specific binding was significantly enhanced after the decrease of extracellular serotonin. These results were confirmed by the 18F-MPPF distribution in cerebral tissues (hippocampus-to-cerebellum ratio) and by the decrease of the extracellular 18F-MPPF collected in hippocampal dialysates. Conclusion: This study further supports the view that 18F-MPPF binding potential is increased in the hippocampus if the endogenous serotonin is pharmacologically decreased after a p-EPA injection. This phenomenon will be an additional factor in the interpretation of the results from 18F-MPPF clinical PET studies.
Key Words: serotonin receptors p-ethynylphenylalanine 4,2'-(methoxyphenyl)-1-[2'-(N-2''-pyridinyl)-p-fluorobenzamido]-ethylpiperazine serotonin microdialysis ß-microprobe
This article has been cited by other articles:
![]() |
L. Truchot, S. N. Costes, L. Zimmer, B. Laurent, D. Le Bars, C. Thomas-Anterion, B. Croisile, B. Mercier, M. Hermier, A. Vighetto, et al. Up-regulation of hippocampal serotonin metabolism in mild cognitive impairment Neurology, September 4, 2007; 69(10): 1012 - 1017. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY | THE JOURNAL OF NUCLEAR MEDICINE |